• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Can B Corp.

    11/13/24 5:13:03 PM ET
    $CANB
    Get the next $CANB alert in real time by email
    NT 10-Q 1 formnt10-q.htm

     

     

     

      UNITED STATES OMB APPROVAL
      SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058
      Washington, D.C. 20549 Expires: March 31, 2022
        Estimated average burden
      FORM 12b-25 hours per response ............. 2.50
       
        SEC FILE NUMBER
      NOTIFICATION OF LATE FILING 000-55753
        CUSIP NUMBER
        13470W103

     

    (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D
      ☐ Form N-SAR ☐ Form N-CSR      

     

      For Period Ended: September 30, 2024
       
      ☐ Transition Report on Form 10-K
      ☐ Transition Report on Form 20-F
      ☐ Transition Report on Form 11-K
      ☐ Transition Report on Form 10-Q
      ☐ Transition Report on Form N-SAR
       
      For the Transition Period Ended: __________________________________________

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

     

     

    PART I — REGISTRANT INFORMATION

     

    Can B̅ Corp.

    Full Name of Registrant

     

    Canabiola, Inc.

    Former Name if Applicable

     

    960 South Broadway, Suite 118

    Address of Principal Executive Office (Street and Number)

     

    Hicksville, New York, New York 11801

    City, State and Zip Code

     

     

     

     
     

     

    PART II — RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

      (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
    ☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
      (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III — NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    (Attach extra Sheets if Needed)

     

    The Registrant is unable to file the Form 10-Q for the period ended September 30, 2024 within the prescribed time period due to a delay in obtaining and compiling information required to be included in the Registrant’s Form 10-Q, which delay could not be eliminated by the Registrant without unreasonable effort and expense. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Registrant will file its Form 10-Q no later than the fifth calendar day following the prescribed due date.

     

    PART IV — OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification

     

    Marco Alfonsi   (516)   595-9544
    (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes ☒ No ☐

     

    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof ?
      Yes ☐ No ☒
       
      If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    2
     

     

    Can B̅ Corp.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: November 13, 2024 By: /s/ Marco Alfonsi
        Marco Alfonsi, Chief Executive Officer

     

    INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

     

    ATTENTION

    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

     

    3

    Get the next $CANB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CANB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CANB
    SEC Filings

    View All

    SEC Form 15-12G filed by Can B Corp.

    15-12G - Can B Corp (0001509957) (Filer)

    7/16/25 11:16:04 AM ET
    $CANB

    SEC Form NT 10-K filed by Can B Corp.

    NT 10-K - Can B Corp (0001509957) (Filer)

    3/28/25 3:43:51 PM ET
    $CANB

    SEC Form EFFECT filed by Can B Corp.

    EFFECT - Can B Corp (0001509957) (Filer)

    1/27/25 12:15:04 AM ET
    $CANB

    $CANB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company

    Primary Focus on Protecting and Commercializing Cannabis Patents HICKSVILLE, N.Y., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Can B Corp. (OTCQB:CANB) ("Can B" or the "Company") today announced that it has implemented a reorganization in which a new holding company, Nascent Pharma Holdings, Inc., has become the publicly-traded parent of Can B and its subsidiaries.  As a result of the reorganization, existing shares of Can B stock have been automatically converted, on a one-for-one basis, into shares of common stock of Nascent Pharma Holdings, Inc.  The Board and executive officers of Can B will continue in the same roles at Nascent Pharma Holdings, Inc. In March 2024, Can B announced that

    10/30/24 8:00:00 AM ET
    $CANB

    Can B Corp. Completes Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange

    HICKSVILLE, NY, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and durable medical devices, is pleased to announce it has successfully completed a corporate debt restructuring. Through the restructuring, Can B raised $1.55 million of new capital and extended previously due notes payable totaling $7.0 million to September 1, 2023, and December 31, 2024.  Specifically, three Promissory Notes issued to three funds in early 2022 and three Promissory Notes issued to three private investors in late 2022 were restructur

    3/15/23 11:49:00 AM ET
    $CANB

    Forever Brands Signs Manufacturing Agreement with Imbibe Wellness Solutions, LLC, a wholly owned subsidiary of Can B Corp for the Production of a new Plant Based Super Food Brand, Longevity by Brooke Burke Body TM.

    NEW YORK , July 26, 2022 /PRNewswire/ -- Forever Brands, a wholly owned subsidiary of ZA Group, Inc (OTCQB:ZAAG), has signed a manufacturing agreement with Imbibe Wellness Solutions, LLC a wholly owned subsidiary of Can B Corp (OTCQB:CANB) for the production of a new brand of Plant Based Super Food, Longevity by Brooke Burke Body TM. Can B develops consumer products at their State-of-the-Art-Research & Development facility in Lacey, WA. The Company develops, produces and test all products under the highest industry standards with independent lab testing. Can B issues Certificates of Analysis for all products! "This is a major milestone in our plan for launching Longevity on schedule. Securin

    7/26/22 8:00:00 AM ET
    $CANB

    $CANB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Can B Corp.

    SC 13G/A - Can B Corp (0001509957) (Subject)

    11/14/24 1:37:09 PM ET
    $CANB

    SEC Form SC 13G/A filed by Can B Corp. (Amendment)

    SC 13G/A - Can B Corp (0001509957) (Subject)

    2/14/24 4:38:08 PM ET
    $CANB

    SEC Form SC 13G/A filed by Can B Corp. (Amendment)

    SC 13G/A - Can B Corp (0001509957) (Subject)

    2/14/24 11:52:26 AM ET
    $CANB